Recent U.S. Customs and Border Protection rulings from CROSS, searchable by HTS code, keyword, or ruling number.
In your letter dated September 9, 2026, you requested a tariff classification ruling. Diltiazem Hydrochloride, imported in 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg extended-release capsules, is in a class of medications called calcium-channel blockers. It is indicated for the treatment of hypertension (high blood pressure) and to manage chronic stable angina.
Source: rulings.cbp.gov (CROSS). This index holds New York rulings from the recent period and the Headquarters rulings they cite. It is not the full CROSS database of 222,467 rulings, and it does not hold every Headquarters ruling. New rulings usually appear here within a few days of CBP publishing them; a ruling published long after its number was assigned can take several weeks. A ruling is marked revoked or modified only when an indexed Headquarters ruling says so, so the absence of a mark is not confirmation that a ruling is still in effect. A ruling letter is binding on CBP only for the particular transaction or issue it describes (19 CFR 177.9). Confirm the text and status on CROSS before relying on a ruling. Not legal advice.